News

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing within three months. ... The heart protection you never knew about semaglutide.
Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing cardiovascular disease but not diabetes ...
*Please mention the European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14) if using this research* Semaglutide can rapidly reduce heart attacks and other serious cardiovascular ...
For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...
In a nutshell People with type 2 diabetes taking semaglutide (Ozempic/Wegovy) showed up to 46% lower dementia risk compared ...
Dr. Dustin T. Smith and Dr. Joanna M. Bonsall reviewed nine key updates in hospital medicine at SHM Converge 2025.
Semaglutide therapy in patients with obese heart failure leads to marked weight loss and notable gains in mood, function, and ...
Effects of Oral Semaglutide on Cardiovascular (and Other) Outcomes in People with Type 2 Diabetes at High CV Risk; Sunday, June 22 at 4:30 - 6:00 PM CT; About the ADA's Scientific Sessions ...
Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...